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Pulmonary Function and Aging
Hemodynamic measurements. Lack of a simple. re-
producible technique for measuring pressure in the pul-
monary circulation in patients with lung disease has ham-
pered physiologists and epidemiologists interested in the
pathophysiology and demographics of pulmonary hyperten-
sion. In contradistinction to the systemic circulation . rela-
tively little is known about the effect of age and aging on
pulmonary artery pressures in healthy individuals. Holm-
gren et al. (1) and Ekelund and Holmgren (2) performed
right heart catheterization in 16 healthyolder men (aged 61
to 83 years). Pressures and flows were recorded at rest and
during subrnaximal supine bicycle exercise. Hemodynamic
measurements obtained from these healthy elderly subjects
were compared with data from 36 healthy young men who
performed the same test protocol. Rest pulmonary artery
mean pressures and pulmonary vascular resistances were
slightly higher in the elderly subjects. During submaximal
exercise, mean pulmonary artery and pulmonary capillary
wedge pressures increased as did cardiac output. and the
slope of the regression line relating pulmonary pressure to
cardiac output was steeper in the elderly.
Pulmonary vascular resistance decreased with exercise
in both age groups, but the decrease was greater in younger
individuals as comparedwith theirolder counterparts. From
these and other studies. it appears that decrements in pul-
monary arterial vascular compliance occur with aging even
in normal, healthy individuals, but the changesare relatively
small, and hemodynamic measurements in healthy agedsub-
jects are generallywithinthe rangeof values seen at younger
ages 0-4),
Aging and pulmonary structure and function. These
findings arc compatible with what is knownabout theeffects
of age on other aspectsof lung structureand function . There
is a progressive decline in ventilatory function and pul-
monary diffusing capacity and increasing nonuniformity of
functionafter the age of 35. The basic physiologic alteration
appears to be an age-dependent change in the elastic char-
acteristics of the lung (5). This is accompanied by an in-
crease in alveolar size observed morphometrically. All of
these findings suggest that aging produces mild diffuse con-
nective tissue changes that lead to a decreased reserve of
the pulmonary vascular bed as well as a decrease in ven-
tilatory function.
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Response to hypoxemia. There are no data concerning
the effect of age on the pulmonary vascular response to
hypoxemia. Because hypoxemia is considered a major de-
terminant of the pulmonary hypertension accompanying
chronic pulmonary disorders, such information would be
invaluable in understanding the effect of age on pulmonary
heart disease.
Specific Causes of Pulmonary Heart Disease
(Precapillary Pulmonary Hypertension)
The commonest causes of precapillary pulmonary hy-
pertension in the United States are chronic pulmonary dis-
ease (such as emphysema and chronic fibrosing alveolitis),
pulmonary embolism, congenital heart lesions with second-
ary pulmonary vascular disease and primary pulmonary hy-
pertension. Other thananecdotal information , little is known
aboutany potentialadditive effectof age on theseconditions
or even how commonly some of these illnesses occur in an
elderly population.
Chronic Obstructive Pulmonary Disease
Chronic obstructivepulmonary disease is the commonest
cause of cor pulmonale and right ventricular failure, and
the majority of deaths from chronic obsttuctive pulmonary
disease occur after the age of 65. The degree of pulmonary
hypertension in these patients is more closely related to the
severity of hypoxemia than to the extent of the ventilatory
impairment (6). The improved survival with supplemental
oxygen in hypoxemic patients with chronic obstructive pul-
monary disease (7 ) is generally ascribed to its beneficial
effects on the pulmonary circulation.
Ventricular function. Although there is still debate,
most authorities believe that left as well as right ventricular
function is compromised in elderly patients with chronic
obstructive pulmonary disease (8). There is a problem, how-
ever, in totally excluding the presence of concomitant heart
disease in these patients. especially among the elderly. In-
deed, the diagnosisof cor pulmonalein elderly patients with
chronic obstructive pulmonarydisease is difficult. The clas-
sic electrocardiographic findings of right ventricular hyper-
trophy are often absent. Newer diagnostic techniques, in-
cluding isotopic studies and possibly echocardiographic
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methods, may allow better assessment of right ventricular
function and provide indirect evidence of pulmonary hy-
pertension. It remains uncertain. however. whether these
techniques arc sufficiently precise to allow one to follow
the course of pulmonary hypertension in order to assess the
effects of therapeutic measures. The reference standard for
quantifying pulmonary hypertension remains direct mea-
surement of pulmonary artery pressure with a pulmonary
artery catheter (9).
Chronic obstructive pulmonary disease and mortal-
ity. Whether or not there is obvious cardiac disease, a high
mortality rate is noted in older patients with chronic ob-
structive pulmonary disease (10), and this is related, at least
in part, to a high rate of complicating cardiovascularprob-
lems. Iii this regard, it is interesting that mortality is much
less closely related to the severity of the ventilatory abnor-
mality in subjects > 65 years than in younger patients with
chronic obstructive pulmonary disease (10). The degree of
pulmonary hypertension that develops in older patients may
be accentuatedbecauseof the decreased pulmonary vascular
compliance that occurs with age.
Pulmonary Embolism
Pulmonary embolism is common in geriatric patients in
whom risk factors for this condition abound (sedentary ex-
istence, prolonged periods of bed rest, cardiopulmonary
disease). Indeed, Dalen and Alpert (11) estimated that as
manyas 25% of deaths in nursing homesand chronicdisease
hospitalsmightbe attributable, at least in part, to pulmonary
embolism. In most of these cases, however, the pulmonary
embolism represents a complication (and sometimes a ter-
minal event) in the course of a serious underlying disorder
and may be difficult to recognize (12). The syndrome of
chronic cor pulmonale secondary to recurrent pulmonary
embolism is infrequently recognized among the elderly. This
may reflect the inherent problems in diagnosing pulmonary
embolism in this age group in which areas of decreased lung
perfusion may be found by isotopic scanning even in the
absence of embolic disease.
Congenital Heart Disease
Few patients with pulmonary vasculardisease secondary
to congenital heart disease reach old age, although an oc-
casional patient with an uncomplicated congenital heart le-
sion (such as atrial septal defect or ventricular septaldefect)
may live beyond age 65. Pulmonary vascular resistance
increases progressively with age in patients with large ven-
tricular septal defects, but few of these patients survive
beyond age 45 (13).
Other Causes
In idiopathicfibrosing alveolitis, mortalityincreases with
age (14), an effect that has been attributed to a high rate of
concomitant cardiovascular disease. However, the specific
effect of age on the developmentof pulmonary heart disease
in these patients has not been reported despite the relatively
high prevalence of the disorder among the elderly (14).
Primary pulmonary hypertension is an unusual disorder
that has a predilection for younger adults. However, an-
ecdotal experience (both personal and published) indicates
that this entity occasionally occurs in the elderly. Because
other causes of pulmonary hypertension are far more com-
mon in older patients, the diagnosis may be missed (15).
Passive Pulmona ry Hypertension
Passive pulmonary artery hypertension is almost always
the result of left ventricular failure or mitral valve disease,
or both (16). An occasional patient with long-standing pas-
sive pulmonary hypertension secondary to mitral valve dis-
ease develops reactive pulmonary hypertension that is often
quite severe (16). Because left ventricular failure and mitral
regurgitation are quite common in elderly individuals, mor-
bidity and mortality secondary to these entities with com-
plicating passive (and occasionally reactive) pulmonary hy-
pertension are probablycommon in elderly individuals. The
exact demographics in the elderly of passive and reactive
pulmonary hypertension with or without associated right
ventricularfailure are unknown. It is also unknown whether
the pulmonary circulation of elderly individuals responds
differently to left ventricular failure or mitral valve disease.
or both, than is the case with younger patients.
Therapy of Pulmonary Heart Disease in
the Elderly
Therapeutic interventions that are clearly efficacious in-
clude anticoagulation for patientswith pulmonaryembolism
and supplemental oxygen for patients with hypoxemic chronic
obstructive pulmonary disease. These interventions may lead
to amelioration of pulmonary hypertension and a decrease
in signs and symptoms of right ventricular failure.
Anticoagulant therapy. Anticoagulant therapy, initially
with heparin and subsequently with warfarin, remains the
treatment of choice for pulmonary embolism despite the
increased bleeding risk in the elderly. Chronic anticoagu-
lation with warfarin is believed by some to be of benefit in
patients with primary pulmonary hypertension.
Oxygen therapy. Elderly patients appear to respond to
oxygen therapy as well as do younger individuals. and the
recommendations of the Nocturnal Oxygen Therapy Trial
Group (1 7) are applicable at all ages. Continuous oxygen
supplementation is indicated for all patients with chronic
obstructive pulmonary disease with an arterial oxygen ten-
sion that is persistently < 55 torr at rest. It is also recom-
mended for patients with secondary signs of hypoxemia
(including right ventricularhypertrophy) whose rest arterial
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oxygen tension is < 60 torr- This therapy has been shown
to improve the quality of life and prolong survival.
Vasodilator drugs. Digitalis therapy in patients with
cor pulmonale is marginally efficacious at best, regardless
of the patient' s age. Pulmonary vasodilation with a resultant
decrease in mean pulmonary artery pressure and pulmonary
vascular resistance can be elicited in selected individuals
with primary pulmonary hypertension. lJnfortunarely, how-
ever. pulmonary vascular responsivity to vasodilator drugs
(calcium blockers, hydralazine, nitrates. isoproterenol) ap-
pears to be less common in elderly than in younger patients
with primary pulmonary hypertension. Vasodilator agents
are not indicated for pulmonary hypertension in chronic
obstructive pulmonary disease; they may produce serious
adverse effects in such patients.
Combined cardiac and pulmonary disease. Certain
therapeutic problems may arise when treating patients who
have both cardiac and pulmonary disease, and these are
especially common in elderly patients. The lise of relatively
nonspecific beta-receptor blockers for hypertension or coro-
nary artery disease may induce bronchospasm in patients
with chronic airway disorders. This is sometimes the first
indication of the underlying lung disease. On theother hand.
the beta-blocking agents and theophylline used in patients
with chronic obstructive pulmonary disease may have ad-
verse effects on cardiac function and even induce serious
arrhythmias. particularly if the dosage is not carefully con-
trolled. Corticosteroids, which are so often given to patients
with chronic lung diseases, may have adverse effects on
serum electrolytes and flu id balance. complicating the man-
agement of any concomitant congestive heart failure.
Exercise. Finally, the importance of a regular graded
exercise program in patients with chronic obstructive pul-
monary disease deserves emphasis. Regular exercise. al-
though not producing measurable changes in pulmonary or
cardiac function, minimizes disability from the disease and
can improve the quality of life (18).
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